Interferons, immunity and cancer immunoediting

@article{Dunn2006InterferonsIA,
  title={Interferons, immunity and cancer immunoediting},
  author={Gavin P. Dunn and Catherine M. Koebel and Robert D. Schreiber},
  journal={Nature Reviews Immunology},
  year={2006},
  volume={6},
  pages={836-848}
}
A clear picture of the dynamic relationship between the host immune system and cancer is emerging as the cells and molecules that participate in naturally occurring antitumour immune responses are being identified. The interferons (IFNs) — that is, the type I IFNs (IFNα and IFNβ) and type II IFN (IFNγ) — have emerged as central coordinators of tumour–immune-system interactions. Indeed, the decade-old finding that IFNγ has a pivotal role in promoting antitumour responses became the focus for a… 
Interferon α in cancer immunoediting: From elimination to escape
  • P. Vidal
  • Biology, Medicine
    Scandinavian journal of immunology
  • 2020
TLDR
It is proposed that IFNα has dual opposing roles in cancer development based on the mutational status of its signalling components, which determines the expression of anti‐ or pro‐tumorigenic IFN‐stimulated genes (ISGs).
Type I and II Interferons in the Anti-Tumor Immune Response
TLDR
This review focuses on the immunostimulatory versus immunosuppressive roles of interferons and the mechanisms mediating such effects on both malignant cells and cells of the immune system in the tumor microenvironment.
Type I Interferons: History and Perspectives as Immunotherapeutic Agents Against Cancer
TLDR
This chapter focuses on type I IFNs, which are closely linked to key processes in cancer, such as malignant transformation, differentiation, tumor cell growth, and death, which can compromise the efficacy of the treatment and reduce patient’s quality of life.
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
TLDR
The current knowledge on the pro- and antitumorigenic effects of IFN-γ as part of the complex immune response to cancer is discussed, highlighting the relevance to identify IFn-γ responsive patients for the improvement of therapies that exploit associated signaling pathways.
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.
TLDR
Type I IFNs drive not only the high maturation status of DCs, but also have a direct impact in cytotoxic T lymphocytes, NK cell activation, induction of tumor cell death and inhibition of angiogenesis.
Double-edged effects of interferons on the regulation of cancer-immunity cycle
TLDR
Recent studies suggest that IFNs regulate each step of the cancer immunity-cycle, consisting of cancer antigen release, presentation of antigens and activation of T cells, trafficking and infiltration of effector T cells into the tumor microenvironment, and recognition and killing of cancer cells, which contributes to the understanding of the mechanisms of IFNs in regulating cancer immunity.
The Two Faces of Interferon-γ in Cancer
TLDR
It is proposed that, in fact, IFN-γ treatment is a double-edged sword whose anti- and protumorigenic activities are dependent on the cellular, microenvironmental, and/or molecular context, and inhibition of the IFn-γ/IFN-β receptor pathway may prove to be a viable new therapeutic target for a subset of malignancies.
The untold story of IFN-γ in cancer biology.
Chapter 7 IFN Inducibility of Major Histocompatibility Antigens in Tumors
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 128 REFERENCES
A critical function for type I interferons in cancer immunoediting
TLDR
It is shown that, like IFN-γ, endogenously producedIFN-α/β was required for the prevention of the growth of primary carcinogen–induced and transplantable tumors.
The role of type I interferons in non‐viral infections
TLDR
This review summarizes the current knowledge on the production and function of IFN‐α/β during non‐viral infections in vitro and in vivo.
The three Es of cancer immunoediting.
TLDR
The history of the cancer immunosurveillance controversy is summarized and its resolution and evolution into the three Es of cancer immunoediting--elimination, equilibrium, and escape are discussed.
Interferon-alpha in tumor immunity and immunotherapy.
The Yin and Yang of type I interferon activity in bacterial infection
TLDR
An increasing body of work shows that type I IFNs have an important role in the host response to bacterial infection, and can influence various immune effector mechanisms.
Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ
TLDR
Sp spontaneous tumor development in gene-targeted mice lacking interferon (IFN)-γ and/or perforin (pfp), or the immunoregulatory cytokines, interleukin (IL)-12, IL-18, and tumor necrosis factor (TNF) is described.
Cellular responses to interferon-gamma.
TLDR
Much of the cellular response to IFN-gamma can be described in terms of a set of integrated molecular programs underlying well-defined physiological systems, for example the induction of efficient antigen processing for MHC-mediated antigen presentation, which play clearly defined roles in pathogen resistance.
...
1
2
3
4
5
...